Innovation can’t be stopped by a quarantine. The 2020 annual UCSF-Stanford Pediatric Device Consortium Pitch Competition, originally scheduled to take place at the Stanford University School of Medicine, went off seamlessly in a virtual, but still highly interactive...
It was a full house at the Fogarty Institute’s latest educational seminar titled “Fundraising – Art or Science?” highlighting the need and interest in this important topic. After all, it drives the future of all startups, but is particularly pertinent to early-stage...
Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital. It follows on the heels of a recent string of...
From damp armpits to clammy palms, nearly one in 20 people in the U.S. suffers from hyperhidrosis. Also known as excessive sweating, this condition can significantly impair quality of life, confidence and emotional well-being as it limits activities, work and social...
Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif. Funding success will...
It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to enhance patient care. That’s why we are delighted with recent advances in funding – while...
A banking partner who truly understands your industry and unique business challenges can make all the difference to a company’s success. And that’s what Silicon Valley Bank aims to do – in their words, “help innovators, enterprises and investors move bold ideas...